{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:36:03Z","timestamp":1790649363036,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"French Society of Anaesthesia & Intensive Care Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12913-018-3058-1","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T03:38:07Z","timestamp":1522813087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of analgesics in France, following dextropropoxyphene withdrawal"],"prefix":"10.1186","volume":"18","author":[{"given":"E.","family":"Van Ganse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Belhassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ginoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chr\u00e9tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ecoffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Aubrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"issue":"9399","key":"3058_CR1","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(03)14966-5","volume":"362","author":"H Kehlet","year":"2003","unstructured":"Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003 Dec 6;362(9399):1921\u20138.","journal-title":"Lancet"},{"issue":"4","key":"3058_CR2","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1","volume":"59","author":"V Ventafridda","year":"1987","unstructured":"Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi FA. validation study of the WHO method for cancer pain relief. Cancer. 1987 Feb 15;59(4):850\u20136.","journal-title":"Cancer"},{"issue":"4","key":"3058_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/J354v20n04_09","volume":"20","author":"Committee on the Safety of Medicines of the UK","year":"2006","unstructured":"Committee on the Safety of Medicines of the UK. Overdose risk prompts UK withdrawal of propoxyphene combination. J Pain Palliat Care Pharmacother. 2006;20(4):49\u201350.","journal-title":"J Pain Palliat Care Pharmacother."},{"key":"3058_CR4","unstructured":"European Medicines Agency: European Medicines Agency recommends withdrawal of dextropropoxyphene-containing medicines (25\/06\/2009).2009 http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2009\/11\/news_detail_000074.sjsp . ."},{"key":"3058_CR5","unstructured":"Retrait des m\u00e9dicaments contenant l\u2019association dextropropoxyph\u00e8ne\/parac\u00e9tamol (Di-Antalvic\u00ae et ses g\u00e9n\u00e9riques) ou dextropropoxyph\u00e8ne\/parac\u00e9tamol\/caf\u00e9ine (Propofan\u00ae et ses g\u00e9n\u00e9riques) [Internet]. [cited 2016 May 16]. Available from: http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/19ca2c73609691747d72c18b65dfc21a.pdf"},{"key":"3058_CR6","first-page":"CD001440","volume":"2","author":"SL Collins","year":"2000","unstructured":"Collins SL, Edwards JE, Moore RA, McQuay HJ. Single dose dextropropoxyphene, alone and with paracetamol (acetaminophen), for postoperative pain. Cochrane Database Syst Rev. 2000;2:CD001440.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3058_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1472-8206.2008.00661.x","volume":"23","author":"S Gaubert","year":"2009","unstructured":"Gaubert S, Vi\u00e9 M, Damase-Michel C, Pathak A, Montastruc J-L. Dextropropoxyphene withdrawal from a French university hospital: impact on analgesic drug consumption. Fundam Clin Pharmacol. 2009;23(2):247\u201352.","journal-title":"Fundam Clin Pharmacol"},{"key":"3058_CR8","unstructured":"Recommandations apr\u00e8s le retrait des associations dextropropoxyph\u00e8ne\/parac\u00e9tamol et dextropropoxyph\u00e8ne\/parac\u00e9tamol\/caf\u00e9ine [Internet]. [cited 2016 Apr 27]. Available from: http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/a6497f74fc2f18e8db0022973f9327e1.pdf"},{"key":"3058_CR9","first-page":"338","volume":"b2270","author":"K Hawton","year":"2009","unstructured":"Hawton K, Bergen H, Simkin S, Brock A, Griffiths C, Romeri E, et al. Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: time series analysis. BMJ. 2009;b2270:338.","journal-title":"BMJ"},{"issue":"3","key":"3058_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1365-2125.2009.03472.x","volume":"68","author":"N Tavassoli","year":"2009","unstructured":"Tavassoli N, Lapeyre-Mestre M, Sommet A, Montastruc J-L, French Association of Regional Pharmacovigilance Centres. Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol). Br J Clin Pharmacol. 2009 Sep;68(3):422\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"3058_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/15360288.2010.549553","volume":"25","author":"Food And Drug Administration Public Health Service","year":"2011","unstructured":"Food And Drug Administration Public Health Service. U S Department Of Health And Human Services null. Food and Drug Administration recommends against the continued use of propoxyphene. J Pain Palliat Care Pharmacother. 2011;25(1):80\u20132.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"7122","key":"3058_CR12","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1136\/bmj.315.7122.1565","volume":"315","author":"A Li Wan Po","year":"1997","unstructured":"Li Wan Po A, Zhang WY. Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol. BMJ. 1997;315(7122):1565\u201371.","journal-title":"BMJ"},{"issue":"5","key":"3058_CR13","doi-asserted-by":"publisher","first-page":"e1001213","DOI":"10.1371\/journal.pmed.1001213","volume":"9","author":"K Hawton","year":"2012","unstructured":"Hawton K, Bergen H, Simkin S, Wells C, Kapur N, Gunnell D. Six-year follow-up of impact of co-proxamol withdrawal in England and Wales on prescribing and deaths: time-series study. PLoS Med. 2012;9(5):e1001213.","journal-title":"PLoS Med"},{"key":"3058_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1472-6904-10-6","volume":"10","author":"P Corcoran","year":"2010","unstructured":"Corcoran P, Reulbach U, Keeley HS, Perry IJ, Hawton K, Arensman E. Use of analgesics in intentional drug overdose presentations to hospital before and after the withdrawal of distalgesic from the Irish market. BMC Clin Pharmacol. 2010;10:6.","journal-title":"BMC Clin Pharmacol"},{"issue":"1","key":"3058_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/15563650.2013.872791","volume":"52","author":"SA Handley","year":"2014","unstructured":"Handley SA, Flanagan RJ. Drugs and other chemicals involved in fatal poisoning in England and Wales during 2000 \u2013 2011. Clin Toxicol (Phila). 2014;52(1):1\u201312.","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"3058_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0398-7620(04)99032-3","volume":"52","author":"P Fender","year":"2004","unstructured":"Fender P, Weill A. Epidemiology, public health and medical rates databases. Rev Epidemiol Sante Publique. 2004;52(2):113\u20137.","journal-title":"Rev Epidemiol Sante Publique"},{"key":"3058_CR17","unstructured":"WHOCC - Purpose of the ATC\/DDD system [Internet]. [cited 2017 Dec 15]. Available from: https:\/\/www.whocc.no\/atc_ddd_methodology\/purpose_of_the_atc_ddd_system\/"},{"issue":"2","key":"3058_CR18","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.annfar.2008.12.009","volume":"28","author":"F Adam","year":"2009","unstructured":"Adam F. Comit\u00e9 douleur-anesth\u00e9sie locor\u00e9gionale et le comit\u00e9 des r\u00e9f\u00e9rentiels de la Sfar. [Weak opioids. Pain and Locoregional Anesthesia Committee and the Standards Committee of the French Society of Anesthesia and Intensive Care]. Ann Fr Anesth Reanim. 2009;28(2):e61\u20136.","journal-title":"Ann Fr Anesth Reanim"},{"issue":"1","key":"3058_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2515\/therapie\/2011004","volume":"66","author":"S Bismuth","year":"2011","unstructured":"Bismuth S, Leng EL, Oustric S, Montastruc J-L, Lapeyre-Mestre M. Which analgesic after dextropropoxyphene withdrawal? A survey in a sample of general practitioners in southwest of France. Therapie. 2011;66(1):25\u20138.","journal-title":"Therapie"},{"issue":"11","key":"3058_CR20","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/jama.2013.2403","volume":"309","author":"BM Kuehn","year":"2013","unstructured":"Kuehn BM. FDA: No codeine after tonsillectomy for children. JAMA. 2013;309(11):1100.","journal-title":"JAMA"},{"key":"3058_CR21","unstructured":"CONTRAMAL, TOPALGIC et g\u00e9n\u00e9riques IXPRIM et ZALDIAR - ANSM\u00a0: Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 [Internet]. [cited 2016 May 16]. Available from: http:\/\/ansm.sante.fr\/Activites\/Surveillance-des-stupefiants-et-des-psychotropes\/Medicaments-a-risque-d-usage-detourne-ou-de-dependance\/Medicaments-a-risque-d-usage-detourne-ou-de-dependance\/CONTRAMAL-TOPALGIC-et-generiques-IXPRIM-et-ZALDIAR"},{"issue":"5","key":"3058_CR22","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/lary.24455","volume":"124","author":"CA Prows","year":"2014","unstructured":"Prows CA, Zhang X, Huth MM, Zhang K, Salda\u00f1a SN, Daraiseh NM, et al. Codeine-related adverse drug reactions in children following tonsillectomy: a prospective study. Laryngoscope. 2014;124(5):1242\u201350.","journal-title":"Laryngoscope"},{"issue":"1","key":"3058_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.accpm.2016.01.007","volume":"36","author":"F Aubrun","year":"2017","unstructured":"Aubrun F, Chr\u00e9tien E, Letrilliart L, Ginoux M, Belhassen M, Lanteri-Minet M, et al. What are the therapeutic alternatives to dextropropoxyphene in France? A prescribers\u2019 survey. Anaesth Crit Care Pain Med. 2017;36(1):15\u20139.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"10","key":"3058_CR24","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00228-014-1722-x","volume":"70","author":"L Becquemont","year":"2014","unstructured":"Becquemont L, Delespierre T, Bauduceau B, Benattar-Zibi L, Berrut G, Corruble E, et al. Consequences of dextropropoxyphene market withdrawal in elderly patients with chronic pain. Eur J Clin Pharmacol. 2014;70(10):1237\u201342.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"3058_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/rheumatology\/kem281","volume":"47","author":"L Ottewell","year":"2008","unstructured":"Ottewell L, Walker DJ. Co-proxamol: where have all the patients gone? Rheumatology (Oxford). 2008;47(3):375.","journal-title":"Rheumatology (Oxford)"},{"key":"3058_CR26","doi-asserted-by":"crossref","unstructured":"Duong M, Gulmez SE, Salvo F, Abouelfath A, Lassalle R, Droz C, et al. Usage patterns of single-ingredient and combined paracetamol in France. Br J Clin Pharmacol. 2016;82:498\u2013503.","DOI":"10.1111\/bcp.12957"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3058-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-018-3058-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3058-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T01:55:58Z","timestamp":1571018158000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-018-3058-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3058"],"URL":"https:\/\/doi.org\/10.1186\/s12913-018-3058-1","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,2]]},"assertion":[{"value":"8 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable as this study was based on anonymized claims data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"231"}}